Back to Journals » Drug Design, Development and Therapy » Volume 13

Caplacizumab as an emerging treatment option for acquired thrombotic thrombocytopenic purpura

Total article views   HTML views PDF downloads Totals
11,151 Dovepress* 7,537+ 1,517 9,054
PubMed Central* 3,614 791 4,405
Totals 11,151 2,308 13,459
*Since 17 April 2019
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar